viral
fusogen
envelop
protein
import
target
develop
inhibitor
viral
entri
report
approach
comput
design
peptid
inhibitor
dengu
viru
envelop
e
protein
use
highresolut
structur
data
preentri
dimer
form
protein
use
predict
strategi
togeth
comput
optim
bind
pseudoenergi
abl
design
multipl
peptid
sequenc
show
low
micromolar
viral
entri
inhibitori
activ
two
activ
peptid
design
displac
region
domain
ii
hing
first
domain
idomain
ii
beta
sheet
connect
respect
show
fifti
percent
inhibitori
concentr
mm
respect
focu
form
unit
assay
antivir
peptid
shown
interfer
viru
cell
bind
interact
directli
e
protein
also
caus
chang
viral
surfac
use
biolay
interferometri
cryoelectron
microscopi
respect
peptid
may
use
character
intermedi
state
membran
fusion
process
investig
denv
receptor
molecul
lead
compound
drug
discoveri
openaccess
articl
distribut
term
creativ
common
public
domain
declar
stipul
place
public
domain
work
may
freeli
reproduc
distribut
transmit
modifi
built
upon
otherwis
use
anyon
law
purpos
fusogen
viral
envelop
glycoprotein
multimer
protein
facilit
fusion
viral
target
cell
lipid
membran
initi
infect
membran
fusion
process
energet
favor
essenti
irrevers
consider
kinet
energi
barrier
protein
allow
rapid
membran
fusion
draw
oppos
membran
togeth
either
stabil
provid
activ
energi
surmount
transit
state
way
behav
mani
aspect
like
fusion
catalyst
effect
macromolecular
process
involv
larg
scale
conform
chang
substrat
membran
protein
protein
possess
multipl
interact
surfac
could
target
inhibitor
sever
distinct
type
viral
fusion
protein
includ
class
primarili
alpha
helic
protein
hiv
tm
influenza
ha
class
ii
primarili
beta
sheet
protein
flaviviru
e
alphaviru
mix
helixsheet
protein
includ
herp
viru
gb
rhabdoviru
g
date
progress
viral
fusion
protein
inhibitor
focus
class
alpha
helic
protein
hiv
tm
protein
provid
excel
exampl
target
distinct
interact
surfac
inhibit
hiv
tm
function
homotrim
monom
contribut
two
alpha
helic
region
interact
form
postfus
sixhelix
bundl
inhibit
format
sixhelix
bundl
accomplish
exogen
peptid
mimick
either
two
reciproc
interact
helic
exampl
viral
entri
inhibitor
activ
primarili
beta
sheet
envelop
protein
e
flavivirus
describ
howev
taken
advantag
avail
crystal
structur
flaviviru
e
protein
includ
prefus
postfus
form
author
structur
predict
sever
region
protein
might
target
inhibit
report
use
structur
data
prefus
dengu
e
protein
model
comput
approach
design
new
peptid
inhibitor
entri
approach
make
use
residuespecif
allatom
probabl
discriminatori
function
rapdf
score
identifi
situ
amino
acid
sequenc
like
high
structur
bind
stabil
seven
comput
design
peptid
synthes
test
two
identifi
possess
fifti
percent
vitro
inhibitori
activ
ic
mm
anoth
ic
activ
mm
two
inhibitor
bind
optim
variant
peptid
origin
design
denv
inhibitori
peptid
sequenc
locat
domain
ii
near
domain
idomain
ii
hing
region
entir
novel
peptid
design
extend
beta
sheet
region
compris
first
connect
domain
ii
show
two
peptid
highest
inhibitori
activ
interfer
viru
cell
bind
caus
structur
chang
surfac
virion
bind
specif
purifi
e
protein
caus
agent
dengu
fever
dengu
hemorrhag
fever
dengu
shock
syndrom
denv
emerg
past
sever
decad
import
mosquito
born
viral
diseas
estim
billion
peopl
live
area
risk
epidem
transmiss
million
peopl
infect
annual
complic
situat
four
distinct
serotyp
denv
gener
low
level
immunolog
cross
protect
allow
repeat
epidem
outbreak
popul
phenomenon
antibodi
depend
enhanc
shown
result
sever
diseas
individu
previous
infect
differ
serotyp
specif
treatment
prevent
avail
vector
control
denv
import
target
develop
antivir
vaccin
result
present
indic
denv
e
glycoprotein
multipl
access
surfac
target
distinct
inhibitor
amen
target
ration
inhibitor
design
peptid
inhibitor
design
improv
situ
bind
compar
natur
occur
sequenc
use
residuespecif
allatom
probabl
discriminatori
function
rapdf
xray
diffract
structur
envelop
protein
protein
data
bank
identifi
use
templat
creat
mutant
structur
peptid
deriv
peptid
randomli
select
residu
side
chain
substitut
new
side
chain
substitut
perform
use
backbonedepend
side
chain
rotam
librari
linear
repuls
steric
energi
term
provid
scwrl
version
result
allatom
model
energi
minim
step
use
energi
calcul
dynam
encad
program
rapdf
score
calcul
estim
structur
stabil
given
e
protein
structur
deriv
select
residu
side
chain
substitut
carri
ten
time
amino
acid
produc
best
rapdf
score
select
use
templat
mutat
entir
mutat
process
repeat
time
enabl
rigor
search
peptid
produc
best
rapdf
score
ie
highest
predict
stabil
residu
acid
slide
window
move
n
c
terminu
e
protein
residu
acid
increment
evalu
structur
stabil
pseudoenergi
optim
protocol
use
rapdf
metropoli
mont
carlo
search
algorithm
use
chang
amino
acid
residu
window
one
natur
occur
amino
acid
stabil
correspond
peptid
context
entir
e
protein
structur
evalu
process
iter
time
use
rapdf
target
score
function
metropoli
criterion
use
select
particular
chang
simul
particular
chang
result
better
rapdf
score
lower
pseudoenergi
retain
particular
chang
result
wors
rapdf
score
higher
pseudoenergi
random
choic
base
score
differ
previou
chang
current
one
made
retain
correspond
chang
procedur
enabl
enabl
design
peptid
result
high
structur
bind
stabil
ie
best
rapdf
score
pseudoenergi
also
enabl
surmount
local
minima
encount
search
comput
optim
perform
four
region
correspond
best
rapdf
score
therefor
highest
bind
potenti
within
e
protein
describ
gener
variant
peptid
sequenc
strain
ngc
obtain
r
tesh
univers
texa
galveston
viru
propag
macaca
mulatta
kidney
epitheli
cell
line
atcc
catalog
number
cell
grown
dulbecco
modifi
eagl
medium
dmem
vv
fetal
bovin
serum
fb
mm
glutamax
uml
penicillin
g
mgml
streptomycin
mgml
amphotericin
b
vv
co
peptid
synthes
solidphas
chemistri
purifi
reversephas
high
perform
liquid
chromatographi
confirm
amino
acid
analysi
electrospray
mass
spectrometri
genem
synthesi
viru
surfac
protein
mediat
interact
target
cell
initi
event
process
infect
inhibit
protein
therefor
major
target
develop
antivir
drug
howev
larg
number
differ
virus
distinct
surfac
protein
except
clear
build
novel
molecul
inhibit
appli
comput
bind
optim
strategi
atom
resolut
structur
dengu
viru
serotyp
envelop
protein
gener
peptid
sequenc
interact
strongli
protein
pick
dengu
viru
target
caus
agent
import
mosquito
transmit
viral
diseas
small
number
candid
design
test
identifi
two
differ
highli
inhibitori
peptid
verifi
result
show
peptid
block
viru
cell
bind
interfer
step
viral
entri
alter
surfac
structur
dengu
viral
particl
interact
directli
dengu
viru
envelop
protein
expect
approach
may
gener
applic
viral
surfac
protein
high
resolut
structur
avail
focu
form
unit
assay
target
cell
seed
densiti
cell
well
plate
h
prior
infect
approxim
focu
form
unit
ffu
viru
incub
without
peptid
serumfre
dmem
h
rt
viruspeptid
viru
control
mixtur
allow
infect
confluent
target
cell
monolay
h
rock
everi
time
medium
aspir
overlaid
fresh
vv
fb
contain
wv
seaplaqu
agaros
cambrex
bio
scienc
rockland
without
rins
cell
agar
overlay
incub
set
agar
infect
cell
incub
co
day
infect
cultur
fix
formalin
overnight
permeabl
vv
ethanol
rins
phosphat
buffer
salin
ph
pb
prior
immunostain
viru
foci
detect
use
specif
mous
mab
hybridoma
obtain
diamond
washington
univers
follow
horseradish
peroxidaseconjug
goat
antimous
immunoglobulin
pierc
rockford
il
develop
use
aec
chromogen
substrat
dako
carpinteria
ca
result
express
averag
least
two
independ
trial
three
replic
ic
valu
determin
use
variabl
slope
sigmoid
doserespons
curv
fit
graphpad
prism
softwar
lajolla
ca
except
determin
graphic
due
lack
data
point
produc
reason
curv
fit
cytotox
peptid
measur
monitor
mitochondri
reductas
activ
use
tac
tm
mtt
cell
prolifer
assay
r
system
inc
minneapoli
mn
accord
manufactur
instruct
dilut
peptid
serumfre
dmem
ad
confluent
monolay
cell
plate
h
similar
focu
form
inhibit
assay
incub
vv
co
h
absorb
nm
measur
use
tecan
geniospro
plate
reader
tecan
us
durham
nc
ngc
strain
use
cryoem
reconstruct
propag
mosquito
cell
viru
purifi
precipit
peg
ultracentrifug
onto
sucros
cushion
viru
purifi
band
potassium
tartrat
gradient
viru
band
remov
dialyz
mm
tri
ph
mm
nacl
mm
edta
concentr
use
millipor
centricon
filter
purifi
viru
mix
concentr
molecul
peptid
everi
e
protein
surfac
viru
complex
incub
half
hour
follow
half
hour
flash
frozen
holey
carbon
grid
liquid
ethan
imag
frozen
complex
taken
philip
feg
transmiss
electron
microscop
philip
eindhoven
netherland
magnif
use
electron
dose
approxim
use
chargecoupl
devic
real
time
bind
assay
peptid
purifi
e
protein
perform
use
biolay
interferometri
octet
qk
system
fortebio
menlo
park
ca
system
monitor
interfer
light
reflect
surfac
fiber
optic
sensor
measur
thick
molecul
bound
sensor
surfac
purifi
recombin
truncat
e
protein
obtain
hawaii
biotechnolog
honolulu
hi
peptid
ntermin
biotinyl
molar
ratio
nhslclcbiotin
piercethermofish
rockford
il
pb
ph
excess
biotinyl
reagent
remov
use
pepclean
spin
column
piercethermofish
rockford
il
biotinyl
peptid
coupl
kinet
grade
streptavidin
high
bind
biosensor
fortebio
menlo
park
ca
sever
differ
concentr
sensor
coat
peptid
allow
bind
e
protein
pb
vv
mgml
bsa
sever
differ
e
protein
concentr
bind
kinet
calcul
use
octet
qk
softwar
packag
fit
observ
bind
curv
bind
model
calcul
associ
rate
constant
e
protein
allow
dissoci
incub
sensor
pb
dissoci
curv
fit
model
calcul
dissoci
rate
constant
bind
affin
calcul
kinet
dissoci
rate
constant
divid
kinet
associ
rate
constant
approxim
ffu
without
peptid
allow
bind
enter
target
cell
h
describ
focu
form
unit
assay
unbound
viru
remov
rins
pb
peptid
ad
cell
h
cultur
wash
pb
agaros
overlay
incub
immunolog
detect
conduct
describ
focu
form
unit
assay
approxim
ffu
allow
attach
cell
min
rins
cold
pb
peptid
incub
target
cell
min
cell
rins
cold
pb
agaros
overlay
incub
immunolog
detect
conduct
describ
focu
form
unit
assay
hemagglutin
inhibit
hi
perform
accord
adapt
microtit
plate
bind
inhibit
assay
modifi
thaisomboonsuk
et
al
briefli
monolay
rins
dmem
contain
bsa
mm
hepe
ph
viru
incub
peptid
control
antidengu
serum
heparan
sulfat
dmembsahep
one
hour
ad
monolay
hour
monolay
rins
time
cold
dmembsahep
media
prior
rna
extract
use
qiagen
rneasi
mini
kit
valencia
ca
per
manufactur
instruct
quantit
real
time
revers
transcriptas
polymeras
chain
reaction
qrtpcr
conduct
util
roch
lightcycl
rna
master
sybr
green
qrtpcr
kit
basel
switzerland
use
primer
denf
ttagaggagacccctccc
denr
tctcctctaacctctagtcc
chutinimitkul
et
al
follow
cycl
condit
h
follow
cycl
cp
valu
use
estim
infecti
unit
accord
standard
curv
independ
assay
repeat
three
time
duplic
triplic
graph
gener
use
kaleidagraph
graph
softwar
synergi
softwar
read
pa
statist
analys
perform
use
graphpad
prism
softwar
packag
graphpad
softwar
san
diego
ca
p
valu
less
consid
signific
previous
identifi
sever
e
protein
region
peptid
mimick
e
protein
sequenc
might
function
inhibitor
sever
mimic
peptid
show
substanti
denv
inhibitori
activ
includ
peptid
deriv
domain
ii
fusion
sequenc
correspond
amino
acid
e
protein
two
overlap
peptid
deriv
domain
ii
hing
region
correspond
amino
acid
respect
predict
crystal
structur
well
previous
confirm
inhibitori
activ
analog
wnv
domain
ii
hing
region
peptid
lent
support
idea
domain
ii
hing
region
attract
target
inhibit
energi
minim
peptid
sequenc
comput
optim
structur
stabil
bind
target
region
evalu
residuespecif
allatom
probabl
discriminatori
function
rapdf
select
character
evalu
sequenc
gener
best
rapdf
score
pseudoenergi
structur
stabil
bind
much
better
lower
origin
wild
type
sequenc
see
tabl
origin
optim
sequenc
sequenc
select
synthesi
evalu
antivir
activ
identifi
addit
novel
peptid
inhibitor
correspond
target
residu
slide
window
move
n
c
terminu
strain
e
protein
pdb
id
residu
acid
increment
evalu
structur
stabil
pseudoenergi
optim
protocol
use
rapdf
metropoli
mont
carlo
search
algorithm
use
chang
amino
acid
residu
window
one
natur
occur
amino
acid
stabil
correspond
peptid
context
entir
e
protein
structur
evalu
approach
identifi
four
e
protein
region
potenti
highest
situ
bind
affin
correspond
strain
e
protein
amino
acid
see
figur
select
synthesi
antivir
test
order
verifi
effect
bind
optim
process
peptid
design
synthes
peptid
test
antivir
activ
strain
ngc
focu
form
unit
ffu
reduct
assay
strain
genbank
access
number
ngc
genbank
access
number
share
amino
acid
sequenc
ident
e
protein
major
differ
conserv
dose
respons
curv
gener
optim
peptid
shown
figur
domain
ii
region
peptid
display
ic
valu
mm
mm
mean
sem
respect
inhibit
infect
observ
fusion
region
peptid
correspondingli
maximum
inhibit
achiev
mm
mm
name
sequenc
previous
test
wild
type
peptid
denot
asterisk
comput
design
peptid
wild
type
sequenc
peptid
scrambl
control
peptid
shown
inhibitori
concentr
ic
valu
sem
determin
sigmoid
curv
fit
dose
respons
curv
figur
given
test
peptid
achiev
inhibit
note
dash
line
peptid
test
antivir
activ
note
nd
data
show
improv
inhibit
compar
nonoptim
counterpart
show
nearli
fold
fold
increas
respect
inhibit
equival
concentr
activ
inhibitor
chosen
studi
scrambl
version
display
inhibit
concentr
test
figur
four
de
novo
design
peptid
also
test
inhibitori
activ
use
ffu
reduct
assay
figur
found
effect
inhibitor
infect
ic
mm
maximum
inhibit
mm
scrambl
version
inhibit
infect
concentr
test
figur
addit
full
dose
respons
inhibit
experi
use
approxim
infecti
unit
viru
peptid
also
capabl
inhibit
infecti
unit
viru
data
shown
toxic
could
result
decreas
focu
format
interpret
evid
antivir
activ
inhibitori
peptid
scrambl
version
assess
cellular
toxic
confluent
monolay
cell
use
ffu
reduct
assay
expos
increas
concentr
peptid
measur
mitochondri
reductas
activ
use
mtt
mitochondri
reductas
activ
assay
figur
initi
perform
assay
exactli
mimic
focu
form
unit
assay
wait
five
day
peptid
exposur
saw
evid
toxic
concentr
peptid
data
shown
howev
found
shorter
postexposur
incub
time
reveal
subtl
toxic
part
one
peptid
appar
wait
h
postexposur
give
cell
chanc
recov
conceal
effect
h
postexposur
found
mildli
toxic
cell
mm
oneway
anova
dunnet
post
hoc
test
p
n
inhibitori
data
use
lower
nontox
concentr
consid
peptid
cryoelectron
microscopi
cryoem
use
visual
effect
peptid
viral
particl
control
dengu
virion
exhibit
normal
nearli
smooth
outer
surfac
typic
matur
flavivirus
surfac
viru
particl
werebecom
followingrough
treatment
peptid
impli
possibl
rearrang
envelop
glycoprotein
figur
treat
virion
longer
show
icosohedr
symmetri
attempt
reconstruct
structur
viru
complex
structur
impos
icosahedr
symmetri
fail
indic
virus
longer
icosahedr
control
treatment
equival
dmso
alon
produc
morpholog
alter
biolay
interferometri
perform
examin
bind
peptid
purifi
truncat
e
protein
amino
termin
biotinyl
peptid
immobil
onto
streptavidin
biosensor
associ
dissoci
truncat
e
protein
immobil
peptid
monitor
interact
three
differ
concentr
truncat
e
protein
peptid
shown
figur
buffer
blank
contain
e
protein
run
peptid
affin
peptid
truncat
e
protein
calcul
bind
model
dissoci
rate
constant
k
k
previous
use
system
character
bind
affin
sever
human
monoclon
antibodi
denv
e
protein
order
determin
peptid
exert
effect
postentri
step
viru
replic
cycl
allow
infect
cell
peptid
ad
cell
figur
inhibit
viral
replic
observ
concentr
figur
assay
figur
indic
peptid
act
postinfect
step
sinc
determin
inhibit
peptid
occur
viral
entri
step
ask
infect
could
still
inhibit
viru
bound
surfac
target
cell
bound
viru
cell
treat
increas
concentr
warm
cell
back
allow
infect
progress
figur
inhibit
viral
entri
observ
peptid
ad
viru
bound
target
cell
determin
peptid
interefer
viru
cell
interact
conduct
two
differ
experi
first
perform
design
entri
inhibitor
peptid
wwwplosntdsorg
hemagglutin
inhibit
assay
unabl
detect
inhibit
abil
viral
antigen
agglutin
red
blood
cell
data
shown
investig
viru
cell
bind
relev
system
treat
viru
bound
viru
cell
wash
cell
repeatedli
measur
amount
viru
remain
cell
quantit
rtpcr
peptid
show
evid
abil
block
viru
cell
bind
compar
control
viru
without
peptid
figur
treatment
viru
pool
human
antidengu
serum
heparan
sulfat
similarli
show
reduc
cell
bind
use
comput
method
design
multipl
peptid
inhibitor
denv
e
glycoprotein
importantli
seven
peptid
synthes
test
two
peptid
high
activ
one
peptid
intermedi
activ
identifi
high
resolut
crystal
structur
prefus
conform
e
use
start
point
gener
situ
energi
minim
peptid
two
distinct
approach
use
design
peptid
first
built
upon
previou
work
target
denv
fusion
peptid
domain
ii
hing
region
natur
occur
e
protein
sequenc
region
inhibitori
activ
found
optim
fusion
peptid
region
sequenc
indic
region
may
promis
target
mechanist
denv
peptid
inhibitor
sinc
analog
natur
occur
wnv
domain
ii
hing
region
peptid
shown
inhibitori
wnv
reason
tightli
bind
analog
region
denv
e
protein
could
design
might
improv
inhibitori
activ
turn
correct
identifi
two
distinct
bindingoptim
peptid
sequenc
region
antivir
activ
support
previou
predict
hing
region
inhibitor
propos
mechan
fusion
base
hing
region
movement
second
approach
design
peptid
inhibitor
identifi
peptid
nonn
sequenc
deriv
e
protein
region
highli
stabl
term
structur
bind
evalu
allatom
score
function
rapdf
identifi
four
region
use
deriv
addit
optim
peptid
figur
four
result
peptid
test
one
identifi
antivir
activ
confirm
use
slide
window
rapdf
minim
approach
find
tightli
bind
protein
ligand
perhap
surpris
comput
bind
optim
increas
activ
previous
inact
peptid
base
natur
occur
e
protein
sequenc
natur
occur
sequenc
multipl
balanc
select
pressur
may
limit
bind
stabil
vivo
combin
use
primari
sequenc
predict
tool
structur
optim
tool
valuabl
approach
find
bind
partner
inhibitor
protein
target
neither
peptid
show
inhibitori
activ
ad
directli
cell
infect
alreadi
occur
indic
peptid
act
entri
step
viru
life
cycl
sequenc
scrambl
version
two
activ
peptid
inact
confirm
sequenc
specif
activ
peptid
also
block
viru
cell
bind
still
capabl
inhibit
infect
even
ad
virion
alreadi
bound
surfac
target
cell
cryoem
use
visual
effect
peptid
virion
surfac
virion
appear
chang
smooth
rough
incub
antivir
peptid
suggest
may
alter
arrang
surfac
envelop
protein
figur
biolay
interferometri
use
measur
kinet
bind
peptid
design
entri
inhibitor
peptid
wwwplosntdsorg
solubl
truncat
e
protein
figur
bind
studi
show
direct
interact
peptid
e
protein
affin
mm
rang
rel
fast
onoff
rate
cryoem
imag
demonstr
inhibitori
peptid
probabl
caus
structur
deform
intact
viral
particl
provid
inform
kinet
chang
possibl
peptid
trap
viral
e
protein
conform
part
normal
breath
viral
particl
interfer
cell
bind
entri
peptid
design
optim
bind
prefus
e
structur
show
direct
evid
interact
purifi
monomer
e
protein
virion
particl
peptid
like
function
displac
portion
e
protein
interf
normal
cell
bind
structur
chang
entri
although
separ
primari
protein
sequenc
region
target
design
peptid
partial
adjac
crystal
structur
c
terminu
region
occupi
pocket
surround
region
see
figur
stress
know
structur
bound
inhibit
peptid
e
protein
complex
structur
may
shed
light
mechanist
detail
cell
bind
fusion
taken
togeth
result
support
hypothesi
peptid
interact
directli
e
protein
entri
inhibitor
despit
difficulti
oral
administr
degrad
digest
tract
peptid
may
make
use
antivir
agent
target
viral
envelop
protein
direct
inhibitor
viral
surfac
protein
avoid
major
difficulti
cross
cellular
membran
order
reach
target
exampl
peptid
inhibitor
intercellular
viral
target
proteas
polymeras
would
need
cross
cell
plasma
membran
case
flavivirus
possibl
intern
membran
bound
figur
quantit
revers
transcriptas
pcr
viru
cell
bind
viru
preincub
either
show
reduc
bind
cell
compar
control
viru
without
peptid
preincub
viru
pool
human
antidengu
serum
heparan
sulfat
similarli
show
reduc
cell
bind
indic
signific
differ
other
anova
follow
tukey
posthoc
test
design
entri
inhibitor
peptid
wwwplosntdsorg
replic
assembl
compart
hiv
entri
inhibitor
fuzeon
peptid
context
chronic
infect
repeat
lifelong
inject
problemat
denv
acut
infect
sever
denv
infect
requir
intraven
fluid
support
facilit
deliveri
antidenv
peptid
rout
establish
exist
multipl
distinct
inhibitori
peptid
target
denv
e
glycoprotein
confirm
util
ration
design
use
structur
data
develop
denv
e
protein
inhibitor
applic
strategi
also
possibl
gener
refin
lead
compound
viral
envelop
fusion
protein
would
optimist
propos
singl
antivir
would
provid
effect
treatment
denv
given
enorm
genet
variabl
four
serotyp
multipl
substrain
differ
class
inhibitor
target
e
protein
denv
target
could
form
basi
develop
combin
treatment
plan
combat
diseas
altern
languag
abstract
translat
abstract
thai
ekachai
jenwitheesuk
author
contribut
